Ischemic heart disease — all decisions

The Board denied entitlement to an evaluation in excess of 30 percent for coronary artery disease (CAD) from April 18, 2021 to March 5, 2024.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board granted service connection for ischemic heart disease and diabetes mellitus type II, both presumed to be related to exposure to herbicides during ACDUTRA at Fort McClellan. The claims for benign prostatic hyperplasia, headaches, and skin cancer were remanded.

The Board granted earlier effective dates of March 29, 2016, for the grants of service connection for multiple conditions including hypertension, peripheral vascular disease, scars, kidney disease, femoral artery occlusion, lacunar stroke, erectile dysfunction, cerebral vascular disease, and valvular heart disease.

The Board granted service connection for chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD), as secondary to the Veteran's service-connected conditions.

The Board denied service connection for coronary artery disease, hypertension, and sinusitis as the evidence did not support a finding that these conditions were incurred in or aggravated by active service.

The Board remands the claims for service connection for diabetes mellitus type II and atherosclerotic heart disease to obtain additional evidence, as the Veteran's service treatment records are unavailable and there is insufficient medical evidence to determine the etiology of these conditions.

The Veteran's service-connected disabilities, including PTSD and other conditions, have prevented him from securing or following a substantially gainful occupation.

The Board remands the claims for service connection for monoclonal gammopathy of undetermined significance, Parkinson's like symptoms, and hypertensive heart disease to correct duty to assist errors.

The Board granted service connection for ischemic heart disease, diabetes mellitus type 2, and diabetic peripheral neuropathy of the lower extremities due to presumed exposure to herbicide agents during service.

The Veteran's service-connected allergic rhinitis is granted a rating of 30 percent, the maximum allowed. The claims for increased ratings and service connection for other conditions are denied.

The Board granted service connection for the cause of the Veteran's death, attributing his systolic heart failure, ischemic cardiomyopathy, and coronary artery disease to active military service, including exposure to toxins.

The Board granted an effective date of May 10, 2010, for the award of service connection for ischemic heart disease (IHD) and remanded the issue of entitlement to an initial rating in excess of 10 percent for IHD.

The Board remands the claims for an earlier effective date for a 100 percent disability rating, SMC based on housebound criteria, and DEA benefits due to a need for additional medical evidence.

The Board granted service connection for hypertension and hypertensive heart disease, heart block (claimed as left bundle branch blockage), but denied an initial compensable rating for a scar, status post hernia repair.

The Board denied increased ratings for a heart disability and an acquired psychiatric disorder, as well as earlier effective dates for TDIU and DEA eligibility. The claim for service connection for erectile dysfunction was remanded.

The Board remands the claims for service connection for various conditions, including bilateral pes planus, heart condition, back disorder, osteoporosis, and others, as additional development is necessary.

The Veteran was granted an initial disability rating of 60 percent for ischemic heart disease, effective August 10, 2022.

The Board granted an earlier effective date of February 25, 2020, for the award of service connection for arteriosclerotic heart disease and scar, status post CABG procedure.

The Veteran's heart disability was granted a rating of 100 percent from May 10, 2023, while the claim for a rating in excess of 60 percent prior to that date and TDIU were denied.